Chemcon Speciality Chemicals LimitedQ1 FY27 Results & Financial Update
Chemcon Speciality Chemicals Limited: Q1 FY27 standalone results and company financials – revenue ₹66.49 Cr, PAT ₹10.96 Cr. Explore reported YoY/QoQ movements, margins, business drivers and management commentary. This page does not provide a rating, target price or investment recommendation.
Quarter at a glanceCurrent reported figures.Change figures appear when a comparable reported period is available.
Find an answer
Ask this result
Chart · Market context
Chemcon Speciality Chemicals price & chart
Market priceLoading…
1Y return—Price return
Loading market chart…
TradingView Lightweight Charts™ · Copyright © 2025 TradingView, Inc.TradingView
Market chartPrice chart temporarily unavailableThe price chart could not be loaded right now. The reported financial results remain available above.
Spotted a factual error?Tell us the number, date or statement and we will re-check the underlying records and calculations.Report an error
Quarterly Results AnalysisExplore Chemcon Speciality Chemicals Q1 FY27 quarterly results and earnings: revenue, profit (PAT), EBITDA, margins, YoY and QoQ growth, order book or business updates where reported, financial performance and management commentary. Reported figures and Nivata calculations are shown separately; no buy, sell or hold recommendation is provided.
Quarter overview
Quarterly earnings analysis
For the quarter ended June 30, 2026 (Q1 FY27), Chemcon Speciality Chemicals reported revenue from operations of INR 66.49 crore and a total income of INR 70.21 crore, supported by a bottom-line profit after tax (PAT) of INR 10.96 crore and basic earnings per share (EPS) of INR 2.99.
According to the company's investor presentation, revenue from operations grew 24% year-on-year from INR 53.5 crore in Q1 FY26, while PAT expanded 72% year-on-year from INR 6.4 crore, driven by improved product realizations and steady demand across core categories.
The organic chemicals business experienced notable top-line improvement during the quarter, aided by better realizations in key products such as HMDS, CMIC, bromobenzene, and 2-bromo, despite ongoing pricing pressures from low-cost Chinese imports in select niches.
The inorganic chemicals segment delivered a stable recovery compared to the corresponding period of the previous year, helped by favorable market conditions and stronger demand for inorganic bromides used in oil drilling and fluid applications.
Geographically, domestic sales accounted for 69% of the revenue mix during Q1 FY27 (INR 45.89 crore equivalent), while export sales (inclusive of deemed exports) contributed 31% (INR 20.60 crore equivalent), reflecting balanced market participation across borders.
Total expenses for the quarter stood at INR 55.66 crore, consisting primarily of cost of materials consumed at INR 42.27 crore, employee benefit expenses at INR 5.70 crore, depreciation and amortization at INR 3.75 crore, and other expenses at INR 8.47 crore.
Profit after tax was ₹10.96 Cr for the reported quarter. EPS was ₹2.99 for the reported quarter.
01 · Business model
What does Chemcon Speciality Chemicals do?
Chemcon Speciality Chemicals Limited manufactures specialized chemical products, focusing on organic chemicals such as HMDS (Hexamethyldisilazane), CMIC (2-Chloro-5-methylaminomethylpyridine), bromobenzene, and 2-bromo, alongside a range of inorganic bromides used in oilwell completion and other industrial applications.
The company operates two primary manufacturing facilities located at Manjusar and Gothada near Vadodara, Gujarat, encompassing 10 operational units, an in-house R&D laboratory, and six owned warehouses.
Chemcon holds prominent global market positions, including being the sole domestic manufacturer of HMDS and the world's largest producer of CMIC, serving established pharmaceutical, agrochemical, and oilfield-drilling clients across domestic and international markets.
02 · Historical context
What shaped the business before this quarter
The company was incorporated in 1989 as Gujarat Quinone Private Limited before subsequently changing its name to Chemcon Speciality Chemicals.
Chemcon commenced its HMDS manufacturing business in 2001 and has since grown to become the sole manufacturer of HMDS in India and the third largest worldwide.
The company expanded its product suite by initiating commercial sales of CMIC, calcium bromide (solution), and zinc bromide (solution) between FY14 and FY16.
Chemcon expanded its portfolio further by introducing 2-Bromo with an installed production capacity of 600 MTPA.
The company acquired Shivam Petrochem Industries through a slump sale during FY26 to strengthen its operational footprint.
03 · Financial snapshot
Current-quarter financial snapshot
| Metric | Q1 FY27 |
|---|---|
| Revenue from operations | ₹66.49 Cr |
| Total income | ₹70.21 Cr |
| Profit before tax | ₹14.55 Cr |
| Profit after tax | ₹10.96 Cr |
| EPS | ₹2.99 |
04 · Why it moved
Why the quarter looked the way it did
What drove revenue
Management reported that top-line performance was primarily driven by improved realization levels across key product categories in the organic and inorganic portfolios.
Inorganic chemicals, primarily comprising inorganic bromides for oil drilling, staged a year-on-year recovery supported by improved end-market demand conditions.
What drove margins
Cost of materials consumed represented the largest expenditure item at INR 42.27 crore out of total expenses of INR 55.66 crore.
Management highlighted that improved realization pricing and better operational efficiencies supported higher profitability margins compared to the previous year.
Employee benefit expenses were held at INR 5.70 crore, while depreciation and amortization expenses stood at INR 3.75 crore for the quarter.
05 · Demand, customers & order book
Where demand is coming from
Chemcon maintains long-standing relationships with major pharmaceutical and chemical clients, with its top 5 customers contributing approximately 32% and top 10 customers contributing approximately 48% of business revenue.
Several major clients have maintained commercial relationships with the company for over five years, and select accounts date back more than two decades.
06 · Segments, products & geography
Which parts of the business are doing the work
Segments and products
In Q1 FY27, organic chemicals contributed 75% of business-wise revenue, inorganic chemicals contributed 13%, and other segments contributed 12%.
Total sales volume for Q1 FY27 reached 2,066 MT, comprising 1,236 MT of organic chemicals and 830 MT of inorganic chemicals.
Geography and market mix
Domestic markets accounted for 69% of Q1 FY27 revenue, while exports (inclusive of deemed exports) represented 31%.
The company maintains active export channels to the United States, Italy, South Korea, Germany, China, Japan, UAE, Russia, Spain, Thailand, and Malaysia.
07 · Capacity, projects & execution
What is being built, commissioned or delivered
Capacity, production and utilisation
The company operates with an installed production capacity of 11,400 MTPA for organic chemicals and 15,000 MTPA for inorganic bromides across its manufacturing facilities in Vadodara.
Projects, capex and execution
Management outlined plans to add new manufacturing capacity for organic chemicals through the upcoming P-11 unit facility.
08 · Strategy & new businesses
How the company is trying to change its growth mix
The company continues to move up the chemical value chain by introducing complex downstream derivatives such as bromobenzene and 2-bromo, and expanding its application reach.
09 · Reported developments
What changed operationally
Reported PAT grew by 72% year-on-year to INR 11.0 crore (INR 1,096.29 lakhs) from INR 6.4 crore in Q1 FY26, driven by higher realizations.
EBITDA expanded by 98% year-on-year to INR 15.4 crore in Q1 FY27 from INR 7.7 crore in Q1 FY26 according to company presentation disclosures.
10 · Pressure points & risks
What is not going smoothly
Management noted that pricing pressure from international competitors, particularly low-cost imports originating from China, continues to persist in select product categories.
11 · Items worth noticing
The line items that can distort a quick read
Other income for the quarter stood at INR 3.72 crore (INR 372.38 lakhs), contributing alongside operating revenue to total income of INR 70.21 crore.
12 · Cash flow & balance sheet
Profit is one thing. Cash and funding tell another part of the story.
Capital allocation & funding
Finance costs for Q1 FY27 were reported at INR 0.85 crore (INR 85.38 lakhs).
13 · Management guidance & targets
What management is targeting from here
Management expressed optimism regarding growth prospects for the remainder of FY27, citing improving realizations, traction in newer product lines, and strengthening customer engagement despite global macroeconomic and geopolitical uncertainties.
14 · Beyond the numbers
What changed beyond the numbers
Reported update
Certifications and Compliance
Chemcon holds ISO 9001:2015 and ISO 14001:2015 certifications, is REACH compliant for European markets, and operates as a zero-discharge manufacturing enterprise complying with major Indian environmental protection acts.
15 · Previous-quarter changes
What changed since the previous quarter
Revenue from operations decreased from INR 75.42 crore in Q4 FY26 to INR 66.49 crore in Q1 FY27, while PAT increased from INR 6.37 crore to INR 10.96 crore over the same sequential period.
16 · Key Q&A
The quarter, answered directly
What does Chemcon Speciality Chemicals do?
Chemcon Speciality Chemicals Limited manufactures specialized chemical products, focusing on organic chemicals such as HMDS (Hexamethyldisilazane), CMIC (2-Chloro-5-methylaminomethylpyridine), bromobenzene, and 2-bromo, alongside a range of inorganic bromides used in oilwell completion and other industrial applications.
What is the clearest takeaway from Q1 FY27?
For the quarter ended June 30, 2026 (Q1 FY27), Chemcon Speciality Chemicals reported revenue from operations of INR 66.49 crore and a total income of INR 70.21 crore, supported by a bottom-line profit after tax (PAT) of INR 10.96 crore and basic earnings per share (EPS) of INR 2.99.
What drove revenue or demand?
Management reported that top-line performance was primarily driven by improved realization levels across key product categories in the organic and inorganic portfolios.
What mattered most for margins or profitability?
Cost of materials consumed represented the largest expenditure item at INR 42.27 crore out of total expenses of INR 55.66 crore.
What changed operationally beyond the headline numbers?
The company operates with an installed production capacity of 11,400 MTPA for organic chemicals and 15,000 MTPA for inorganic bromides across its manufacturing facilities in Vadodara.
What is management guiding or targeting from here?
Management expressed optimism regarding growth prospects for the remainder of FY27, citing improving realizations, traction in newer product lines, and strengthening customer engagement despite global macroeconomic and geopolitical uncertainties.
17 · Scenario calculator
Earnings sensitivity: what if growth and margins change?
Starting point
Build your own next-quarter scenario
Reported values are prefilled where a comparable basis is available. Otherwise, the field starts at 0. You can overwrite every field.
Example: enter 10 for 10% revenue growth. Enter -100 for a 1 percentage-point margin decline.
Scenario output
Scenario revenue / income₹0 cr
Scenario profit after tax₹0 cr
Profit change vs base₹0 cr (0%)
Scenario margin0%
Growth needed to keep profit flat after this margin move0%
The calculator holds the selected margin basis constant except for the basis-point adjustment you enter. It does not estimate tax, finance cost, dilution, working capital, valuation or share price.
18 · Next filing checkpoints
What the next disclosure can confirm or change
- 01
P-11 Facility Progress: Monitor updates regarding the construction and commissioning timeline of the P-11 manufacturing unit for organic chemicals.
- 02
Import Pricing Trends: Track the trajectory of global chemical pricing and Chinese import competition impacting domestic realization margins.
Learn the metrics
Need the concepts first?
Use Nivata’s plain-English guides to understand the accounting terms used in this brief before interpreting them.